/ Unknown statusNot Applicable Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
The purpose of the study is to identify molecular markers at the level of molecular pathway activation to predict efficacy of anti-HER2 therapy with Trastuzumab.
100 Clinical Results associated with Vitamed doo
0 Patents (Medical) associated with Vitamed doo
100 Deals associated with Vitamed doo
100 Translational Medicine associated with Vitamed doo